Explore the full management transaction log of 리브스메드, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 리브스메드 has published 4 insider filings. Market capitalisation: €1,401.9bn. The latest transaction was reported on 22 April 2026 — Purchase. Among the most active insiders: 김재헌. Every trade is openly available.